title: Commentary: larazotide acetate - an exciting new development for coeliac patients? Authors' reply.
authors: Celiac Center, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. ckelly2@bidmc.harvard.edu
authors: C P
authors: CP
authors: Kelly
authors: P H R
authors: PH
authors: Green
authors: J A
authors: JA
authors: Murray
authors: A
authors: A
authors: Dimarino
authors: A
authors: A
authors: Colatrella
authors: D A
authors: DA
authors: Leffler
authors: T
authors: T
authors: Alexander
authors: R
authors: R
authors: Arsenescu
authors: F
authors: F
authors: Leon
authors: J G
authors: JG
authors: Jiang
authors: L A
authors: LA
authors: Arterburn
authors: B M
authors: BM
authors: Paterson
authors: R N
authors: RN
authors: Fedorak
mesh_terms: D002446:Celiac Disease / Q000188:drug therapy*; D005260:Female; D005983:Glutens / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D009842:Oligopeptides / Q000627:therapeutic use*
chemical_list: D009842:Oligopeptides; D005983:Glutens